Cardinal Health Inc (CAH)
Cardinal Health Inc (CAH) carries a ŷRobot AI score of 77 out of 100. The model's fair value estimate is $265.85, 4.6% above the last close of $254.06. The chart signal reads Sell.
| Metric | CAH |
|---|---|
| AI score | 77 / 100 |
| Chart signal | Sell |
| Fair value estimate | $265.85 |
| Upside to fair value | 4.6% |
| Previous close | $254.06 |
| P/E | 30.76 |
| Price / sales | 0.21 |
| Market cap | $57.37B |
| EPS | 7.48 |
| Revenue growth | 6.3% |
| 1-year price change | 31.0% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Incorporated, Merck & Company Inc, Novartis AG ADR.
Questions about CAH
Is CAH overvalued or undervalued right now?
As of Oct 16, 2026, ŷRobot's fair-value model estimates Cardinal Health Inc (CAH) at $265.85 against a last close of $254.06, implying 4.6% upside to the model's estimate.
Is CAH's chart signal bullish or bearish?
The chart-signal model classifies CAH as Neutral as of Oct 16, 2026, with a signal score of -0.12 on a -1 to 1 scale.
What is CAH's ŷRobot AI score?
CAH scores 77 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 16, 2026.
Is CAH stock expensive on P/E and P/S?
CAH trades at 30.8 times earnings and 0.2 times sales as of Oct 16, 2026.
What does CAH's seasonal forecast show?
ŷRobot's seasonal forecast curve for CAH reads +4.4% at 30 days, +11.9% at 90 days, and +31.0% at one year as of Oct 16, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is CAH growing?
Cardinal Health Inc's revenue growth is +6.3% and free-cash-flow growth is +5.8% on the latest reported figures.
CAH chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.